Funding rounds / 107
#107
| id | 107 |
|---|---|
| company_id | 166 |
| round_name | Growth |
| announced_date | 2026-05-05 |
| closed_date | — |
| amount_raised_usd | 165000000 |
| pre_money_val_usd | — |
| post_money_val_usd | — |
| source_form_d_id | — |
| source_s1_id | — |
| notes | Led by OrbiMed. Novo Holdings, Blue Owl, Harbour BioMed, SR One, Omega, RTW, Qiming participated. Long-acting antibody therapies. Source:... |
| created_at | 2026-05-07T18:54:15.747456+00:00 |
| updated_at | 2026-05-22T23:25:44.300201+00:00 |
| round_type_id | 12 |
| currency_code | USD |
| source_record_id | — |
| tenant_id | 1 |